ARK BIOSCIENCES
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.
ARK BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.arkbiosciences.com
Total Employee:
51+
Status:
Active
Contact:
+862161630331
Email Addresses:
[email protected]
Total Funding:
40.09 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF SSL By Default Mobile Non Scaleable Content JsDelivr Microsoft Exchange Online Office 365 Mail Pound Sterling
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Akeso Biopharma
Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Genevide
Genevide is a biotech company that specializes in gene research and development.
Laekna Therapeutics
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Vidac Pharma
Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering
Current Advisors List
Current Employees Featured
Founder
Investors List
Oriza Holdings
Oriza Holdings investment in Series D - Ark Biosciences
Oriental Fortune Capital
Oriental Fortune Capital investment in Series D - Ark Biosciences
Qiming Venture Partners
Qiming Venture Partners investment in Series D - Ark Biosciences
Longda Foods
Longda Foods investment in Series D - Ark Biosciences
Loyal Valley Capital
Loyal Valley Capital investment in Series D - Ark Biosciences
FTZ Fund
FTZ Fund investment in Series D - Ark Biosciences
Spinnotec
Spinnotec investment in Series C - Ark Biosciences
Hillhouse Investment
Hillhouse Investment investment in Series C - Ark Biosciences
Boquan Capital
Boquan Capital investment in Series C - Ark Biosciences
Yingke Capital
Yingke Capital investment in Series C - Ark Biosciences
Official Site Inspections
http://www.arkbiosciences.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.3 K
- Host name: 47.100.242.78
- IP address: 47.100.242.78
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Ark Biosciences"
Ark Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +862161630331 Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, …See details»
Ark Biosciences Company Profile | Management and Employees …
Www.arkbiosciences.com Ark Biosciences Profile and History Ark Biosciences is a privately held, clinical stage global biotechnology company with its corporate office located in Zhang Jiang Hi …See details»
Ark Biosciences Inc - Company Profile and News
Company profile page for Ark Biosciences Inc including stock price, company news, executives, board members, and contact informationSee details»
Shanghai Ark Biopharmaceutical Co., Ltd. - Ark Biosciences
Hypertrophic Scars (HS) Hypertrophic scar is a type of pathological scar that results from overgrowth of skin tissue after a traumatic injury. In normal wound healing process, collagen …See details»
Ark Biosciences Company Profile - Office Locations, Competitors
Ark Biosciences has 5 employees at their 1 location and $40 m in total funding,. See insights on Ark Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Ark Biosciences - Overview, News & Similar companies - ZoomInfo
Nov 6, 2019 Ark Biosciences contact info: Phone number: +86 2158350139 Website: www.arkbiosciences.com What does Ark Biosciences do? Ark Biosciences is a privately held, …See details»
Ark Biosciences - Company Profile - Tracxn
Nov 14, 2024 Ark Biosciences - Chinese, clinical-stage biopharma developing small molecule therapeutics for respiratory viral infection and viral hepatitis. Raised funding over 3 rounds …See details»
Ark Biosciences-动脉网 - vbdata.cn
Ark Biosciences是一家生物制药公司，致力于发现和开发创新疗法，以满足全球和中国市场未满足的医疗需求，特别是在呼吸道病毒感染和病毒性肝炎领域。Ark Biosciences致力于建立一家科 …See details»
Ark Biosciences Profile - The Company Check
Jun 29, 2024 Ark Biosciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 137.12% increase.The company also saw a substantial …See details»
ArkBio Company Profile 2024: Valuation, Funding
ArkBio General Information Description. Developer of innovative medicines designed to treat pediatric, respiratory, and lung diseases. The company's medicine is created to address unmet medical needs in the area of respiratory …See details»
Ark Overview - Ark Biosciences
The first non-oncology drug designated breakthrough therapy by the NMPA, AK0529 is the first anti-RSV drug that has successfully completed a phase 3 pivotal clinical study globally.See details»
Organization | Ark Biosciences Inc.
Organization Overview. First Clinical Trial. 2014 NCT02297594. First Marketed Drug. None First NDA Approval. None ... Ark Biosciences Inc. | Ark Biosciences Pty Ltd. | …See details»
Ark Biosciences - Products, Competitors, Financials, Employees ...
For more information about the company, please visit our website: www.arkbiosciences.com. Nov 25, 2024. ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 …See details»
WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical …
May 23, 2023 For more information, please visit www.arkbiosciences.com. ... As a premier Contract Research, Development, and Manufacturing Organization (CRDMO), WuXi STA …See details»
Career - Ark Biosciences
We offer competitive compensation and benefit packages, including annual bonus, project award, and Employee Share Incentive Plan as long-term incentive. In addition to standard social …See details»
Our History - Ark Biosciences
Initiated AK3280's phase 2 study in China Initiated AK3287's phase 1/2 study Ziresovir's phase 3 study completed, primary endpoint & key secondary endpoints met Completed series D round …See details»
Ark Biotech Company Profile 2024: Valuation, Funding ... - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Ark Biotech. Use the PitchBook Platform to explore the full profile.See details»
Ark News - Ark Biosciences
2023-03-16 Ark Biopharmaceutical and Calibr, a Division of Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad …See details»
Ark Biopharmaceutical Enters Into Exclusive License ... - Ark …
Dec 29, 2021 We are thrilled to be collaborating with an organization that shares our excitement about AZSTARYS as a novel treatment option for patients with ADHD, their caregivers, and …See details»